Economic Atlas
Companies/Achieve Life Sciences, Inc.
Company profile

Achieve Life Sciences, Inc.

NASDAQ: ACHV · Healthcare · Biotechnology
Canadian filerHQ Vancouver, BCCIK 0000949858Reports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
37D
Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$54.6M
Employees
28
as of 2026-08-11
Market cap
$684.7M
as of 2026-08-11

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$0$02019
Net income-$54.6M-$54.6M2025
Total assets$41.8M$41.8M2025
Liabilities$20.3M$20.3M2025
Equity$21.5M$21.5M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Achieve Life Sciences, Inc.’s revenue?

Achieve Life Sciences, Inc. booked $0 in FY2019 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare
Design Therapeutics, Inc.55CMonopar Therapeutics Inc.59CAllogene Therapeutics, Inc.39DNeurogene Inc.43DArtiva Biotherapeutics, Inc.41DContineum Therapeutics, Inc.57C
Key facts
CEOAndrew D. Goldberg
SectorHealthcare
IndustryBiotechnology
HeadquartersVancouver, BC
ExchangeNASDAQ: ACHV
Employees28
IPO date1995-10-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.